CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
2500 ppm Carbon Dioxide +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05292378
NCT05292378N/ACompleted

Carbon Dioxide (CO2): A Pilot Study of a Hypothesized Mechanism to Explain Cognitive Impairment

Rutgers, The State University of New Jersey·interventional·Posted Mar 23, 2022·Updated Mar 16, 2026

In Brief

A clinical study evaluating 2500 ppm Carbon Dioxide and 600 ppm Carbon Dioxide for Healthy. Completed, enrolled 27 participants across 1 site.

Detailed Summary

The purpose of the study is to better understand the biological mechanisms of carbon dioxide (CO2)-induced cognitive impairments.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 23, 2022
Enrollment StartJul 14, 2022
Primary CompletionMar 20, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 4.3 years ago

Interventions

2500 ppm Carbon Dioxideother

2.5 hour exposure to 2500 ppm carbon dioxide

600 ppm Carbon Dioxideother

2.5 hour exposure to 600 ppm carbon dioxide